Approval · Notice of Compliance 508 · 2002
ARIXTRA: Notice of Compliance 508
Issued June 13, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 508
- Date
- June 13, 2002
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Synthetic antithrombotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ARIXTRA | 02245531 | Marketed |
Medicinal ingredients
- FONDAPARINUX SODIUM 2.5 MG per 0.5ML